Filing Details
GALECTIN THERAPEUTICS INC (NASDAQ:GALT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:GALT
GALECTIN THERAPEUTICS INC (GALT) Files Quarterly Report for Q0
GALECTIN THERAPEUTICS INC (NASDAQ:GALT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
At publication ·
What changed
GALECTIN THERAPEUTICS INC (NASDAQ:GALT) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Galectin Therapeutics Inc (NASDAQ: GALT) filed its quarterly report (Form 10-Q) on August 14, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $3.44 with a market capitalization of $369.9 million as of the filing date.
- The quarterly report contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual filing.
Market Context
GALECTIN THERAPEUTICS INC's stock currently trades at $3.44 with a market capitalization of $369.9M.
The 10-Q provides GALECTIN THERAPEUTICS INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for GALECTIN THERAPEUTICS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GALT Stock Page
Frequently Asked Questions
Where can I read GALT's SEC filings?
Browse all filings on our GALT SEC filings page.
What types of SEC filings does GALECTIN THERAPEUTICS INC file?
Public companies like GALECTIN THERAPEUTICS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.